AMGN

2 Healthcare Dividend Stocks to Buy as the Tech-Heavy Nasdaq Dips Below Correction Territory

04/02 05:32 pm

Dow, S&P 500, Nasdaq: From Morning Meltdown to Midday "Meh"

04/02 02:25 pm

Trump Administration Prepares 100% Tariffs On Drugmakers Without Pricing Deals: Report

04/02 04:44 am

Rajani Dinavahi, MD, Appointed Chief Medical Officer of Ardelyx

04/01 08:01 am

FDA Warns Of Fatal Liver Risks Linked To Amgen Tavneos Use

03/31 02:05 pm

Teva Gains Biosimilar Momentum with U.S. FDA Approval of PONLIMSI™ (denosumab-adet) and Dual Filing Acceptance for Biosimilar Candidate to Xolair® (omalizumab)

03/30 08:00 am

Teva gewinnt an Dynamik im Biosimilar-Geschäft mit der FDA-Zulassung für PONLIMSI™ (Denosumab-adet) und der Annahme von parallelen Zulassungsanträgen für einen Biosimilar-Kandidaten zu Xolair® (Omalizumab)

03/30 08:00 am

Teva gagne du terrain dans le domaine des médicaments biosimilaires grâce à l’approbation accordée par la FDA pour PONLIMSI™ (dénosumab-adet) et à l’acceptation d’un double dossier pour un candidat biosimilaire à Xolair® (omalizumab)

03/30 08:00 am

This Top ETF Recently Added a Healthy Dose of These High-Yielding Dividend Stocks

03/30 06:30 am

SK pharmteco to Host Innovations in Pharmaceutical Manufacturing Symposium in Cambridge, Massachusetts

03/26 10:00 am

2 Healthcare Stocks to Buy Before They Get Bought Out

03/20 05:34 am

CytomX Therapeutics Announces Pricing of $250 Million Offering of Common Stock and Pre-Funded Warrants

03/17 10:46 pm

Amgen, GSK Set To Join TrumpRx Offering Deep Prescription Drug Discounts: Report

03/16 07:19 am

1 ETF That Could Turn $100 Per Month Into $67,380

03/15 05:05 am

Better Weight Loss Stock: Novo Nordisk Vs. Amgen

03/08 02:30 pm

Cytokines Market Global Forecast 2026-2032: Precise Treatments, Strategic Partnerships, and Supply Chain Resilience Fueling the $95+ Billion Market

03/05 05:44 am

AMGEN ANNOUNCES 2026 SECOND QUARTER DIVIDEND

03/04 05:01 pm

GLP-1 Receptor Agonist Business Analysis Report 2026: Market to Reach $137.4 Billion by 2030 - Clinical Trials Exploring GLP-1 Role in NAFLD and NASH Unlock Future Opportunities

03/04 06:48 am

A Couple's Financial Manifesto, Revisited

03/02 12:19 pm

A Symbol of Crisis: As Colorectal Cancer Deaths Rise, Fight CRC Installs United in Blue on the National Mall

02/27 03:52 pm

One in Three Rheumatologists View BMS’ Sotyktu as a Substantial Advance in Psoriatic Arthritis Ahead of March 6 FDA Decision, According to Spherix Global Insights Data

02/27 01:31 pm

Your Kidneys Count: American Kidney Fund Urges Americans to Protect Their Health this Kidney Month

02/27 10:52 am

VivaVision Eyes Hong Kong Listing Before Cash Coffers Dry Up

02/26 02:46 pm

Advanced Drug Delivery Market to Grow 10.2% Annually Through 2030

02/25 01:54 pm

CVS Caremark Replaces Amgen And Eli Lilly's Branded Drugs, Expands Biosimilar Strategy For Weak Bone Disorder

02/06 02:52 pm

Anti-Obesity Drugs Market to Reach US$195.99 Billion by 2036 as GLP-1 Therapies Drive a Structural Shift in Weight Management

02/06 06:00 am

Amgen Hits 52-Week Highs: Buy Signal?

02/05 04:43 am

Oncology Biosimilars Research and Global Forecast Report 2025-2030: Targeted Therapies, Emerging Market Expansion, and Novel Biosimilar Formulations Drive Growth

02/04 01:54 pm

CytomX Therapeutics to Present at Upcoming February Conferences

02/04 09:00 am

Targeted Cancer Therapy Market to Reach US$ 175.48 Billion by 2035 Driven by Precision Oncology Adoption, ADC Innovation, and Regulatory Productivity Says Astute Analytica

02/03 02:56 am

This Top Non-Tech AI Trade for 2026 Pays a Huge 11.6% Dividend

02/02 07:33 am

Kyowa Kirin erlangt Kontrolle über Entwicklungs- und Kommerzialisierungsprogramm für Rocatinlimab wieder, zeigt starkes Engagement im Bereich des ungedeckten medizinischen Bedarfs bei atopischer Dermatitis

01/31 11:28 am

Kyowa Kirin akan Mengambil Alih Semula Kawalan ke atas Rocatinlimab Development and Commercialization Program, Sekali Gus Menunjukkan Komitmen Kukuh bagi Menangani Keperluan Perubatan Tinggi yang Belum Dipenuhi dalam Dermatitis Atopik

01/31 11:28 am

Kyowa Kirin reprend le contrôle du programme de développement et de commercialisation du rocatinlimab, manifestant ainsi son profond engagement visant à répondre aux besoins médicaux non satisfaits dans le domaine de la dermatite atopique

01/31 11:28 am

協和キリン (Kyowa Kirin)、ロカチンリマブ (Rocatinlimab) の開発・商業化プログラムの管理権を再取得、アトピー性皮膚炎における高いアンメット・メディカル・ニーズへの強いコミットメントを示す

01/31 11:28 am

Kyowa Kirin תשיב לעצמה שליטה על תוכנית הפיתוח והמסחור של רוקטינלימאב, תוך הפגנת מחויבות חזקה לטיפול בצורך רפואי גבוה שלא הגיב בדלקת עור אטופית

01/31 11:28 am

Kyowa Kirin 将重新掌控罗卡替尼单抗的研发及商业化项目，展现其致力于满足特应性皮炎医疗需求巨大缺口的坚定决心

01/31 11:28 am

Kyowa Kirin Recupera Controle do Programa de Desenvolvimento e Comercialização do Rocatinlimab, Demonstrando Forte Compromisso para Abordar a Alta Necessidade Médica Não Atendida na Dermatite Atópica

01/31 11:28 am

Kyowa Kirin recupera el control del programa de desarrollo y comercialización de rocatinlimab, demostrando un firme compromiso para abordar la elevada necesidad médica no cubierta en la dermatitis atópica

01/31 11:28 am

Kyowa Kirin 重掌羅卡替尼單抗的研發和商業化項目，展現出致力解決異位性皮膚炎高度未獲滿足醫療需求的堅定承諾

01/31 11:28 am

Kyowa Kirin Regains Global Rights To Atopic Dermatitis Drug After Amgen Collaboration Ends

01/30 02:09 pm

Missed Out on Eli Lilly? This GLP-1 Stock Could Be a Bargain Buy.

01/28 09:30 pm

Atopic Dermatitis Market to Reach USD 12.97 Billion by 2034, Growing at 7.75% CAGR

01/27 11:00 am

Johnson & Johnson Clears the Patent Cliff as 2026 Guidance Resets the Narrative

01/21 10:43 am

U.S. Bispecific Antibodies Forecast Report 2025-2033: Market to Grow by Over $260 Billion, Driven by Increased Cancer and Autoimmune Diseases, FDA Approvals, and Strategic Partnerships

01/21 05:52 am

Continuous Bioprocessing Market Set to Surpass Valuation of US$ 2,331.98 Million By 2035 | Astute Analytica

01/16 01:38 pm

Actionable Insights in the Dermatology Market: Navigating Technological Advances and Growth Trends

01/16 05:56 am

Amgen Reports MariTide Weight Loss Holds Up With Fewer Doses

01/14 01:36 pm

[Latest] Global T-Cell Engagers Market Size/Share Worth USD 18.8 Billion by 2034 at a 21.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

01/14 04:30 am

The Dogs of the Dow: 10 Downtrodden Dividends Paying Out Up to 6.8%

01/09 08:09 am